Talia Palacios

Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver Disease

L. Vitetta, M. Thomsen, E. T. Saltzman, 2018, Front. Microbiol..

Are the Gut Bacteria Telling Us to Eat or Not to Eat? Reviewing the Role of Gut Microbiota in the Etiology, Disease Progression and Treatment of Eating Disorders

Y. Lam, I. Caterson, S. Maguire, 2017, Nutrients.

Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study

L. Vitetta, C. Madigan, Y. Lam, 2020, Nutrients.

The gastrointestinal microbiota and multi-strain probiotic therapy: In children and adolescent obesity

L. Vitetta, H. Butt, S. Coulson, 2014 .

Perna canaliculus (Green-Lipped Mussel): Bioactive Components and Therapeutic Evaluation for Chronic Health Conditions.

L. Vitetta, S. Coulson, Talia Palacios, 2015, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

Gastrointestinal Tract Commensal Bacteria and Probiotics: Influence on End-Organ Physiology.

L. Vitetta, Sean Hall, S. Coulson, 2015, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

The effect of a novel probiotic on metabolic biomarkers in adults with prediabetes and recently diagnosed type 2 diabetes mellitus: study protocol for a randomized controlled trial

L. Vitetta, C. Madigan, I. Caterson, 2017, Trials.